Abstract

We report on the ongoing project “PREDICT-ADFTD: Multimodal Imaging Prediction of AD/FTD and Differential Diagnosis” describing completed and future work supported by this grant. This project is a multi-site, multi-study collaboration effort with research spanning seven sites across the US and Canada. The overall goal of the project is to study neurodegeneration within Alzheimer’s Disease, Frontotemporal Dementia, and related neurodegenerative disorders, using a variety of brain imaging and computational techniques to develop methods for the early and accurate prediction of disease and its course. The overarching goal of the project is to develop the earliest and most accurate biomarker that can differentiate clinical diagnoses to inform clinical trials and patient care. In its third year, this project has already completed several projects to achieve this goal, focusing on (1) structural MRI (2) machine learning and (3) FDG-PET and multimodal imaging. Studies utilizing structural MRI have identified key features of underlying pathology by studying hippocampal deformation that is unique to clinical diagnosis and also post-mortem confirmed neuropathology. Several machine learning experiments have shown high classification accuracy in the prediction of disease based on Convolutional Neural Networks utilizing MRI images as input. In addition, we have also achieved high accuracy in predicting conversion to DAT up to five years in the future. Further, we evaluated multimodal models that combine structural and FDG-PET imaging, in order to compare the predictive power of multimodal to unimodal models. Studies utilizing FDG-PET have shown significant predictive ability in the prediction and progression of disease.

Highlights

  • Frontotemporal dementia (FTD), with the behavioral variant being the most common form, is the leading cause of dementia in people under the age 60 [1], with an estimated prevalence of 15–22/100,000 [1,2,3]

  • We report on the ongoing project “PREDICT-ADFTD: Multimodal Imaging Prediction of Alzheimer’s dementia (AD)/FTD and Differential Diagnosis” describing completed and future work supported by this grant

  • Several machine learning experiments have shown high classification accuracy in the prediction of disease based on Convolutional Neural Networks utilizing magnetic resonance imaging (MRI) images as input

Read more

Summary

INTRODUCTION

Frontotemporal dementia (FTD), with the behavioral variant (bvFTD) being the most common form, is the leading cause of dementia in people under the age 60 [1], with an estimated prevalence of 15–22/100,000 [1,2,3]. PREDICT-ADFTD: Multimodal Imaging Prediction of AD/FTD and Differential Diagnosis is a four-year award, which is currently in its third year This project was awarded in order to broadly study neurodegeneration using a variety of imaging and computational techniques so that we may be able to develop methods for the early and accurate prediction of disease and its course. The funded project is widely collaborative, with research spanning seven sites across the US and Canada These sites include Northwestern University Feinberg School of Medicine (NUFSM), Simon Frasier University (SFU), University of British Columbia (UBC), Johns Hopkins University (JHU), University of California at San Francisco (UCSF), The Mayo Clinic, and University of Southern California (USC). The primary goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD)

Aims of the Grant
Background
DISCUSSION
Findings
CONCLUSIONS
CONFLICTS OF INTEREST
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call